Enacts the "public university emergency contraception education act" requiring public universities to develop, produce and distribute informational materials related to emergency contraception.
Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.
Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.
Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.
Requires each institution within the state university of New York and the city university of New York offering in-person student instruction to have at least one vending machine making emergency contraception available for purchase.
Provides practical support for access to abortion care including, but not limited to, reimbursement for ground and air transportation, lodging, meals, childcare, translation services, and doula support.
This bill (S 3155) requires health insurers to provide in vitro fertilization (IVF) coverage without discrimination. It prohibits insurers from denying or limiting IVF coverage based on factors like age, disability, sexual orientation, gender identity, or perceived quality of life. The bill specifically bans insurers from requiring all embryos from a previous IVF cycle to be transferred before covering a subsequent cycle for women aged 35 or older. These changes directly affect individuals seeking IVF treatment by expanding access and preventing discriminatory practices in insurance coverage.
This bill allows New York pharmacists to administer FDA-approved progestin-only contraceptive injections, expanding access to this specific form of birth control. It requires pharmacists to complete training, provide patient screening questionnaires and fact sheets about clinical considerations, and notify a patient's primary care provider (unless the patient opts out). The policy directly affects patients seeking contraception and pharmacists who will administer the injections. Key safety mechanisms include mandatory screenings, provider notifications, and pharmacist discretion to refuse service if health risks are identified.
Establishes the comprehensive sexual and reproductive health program to provide funding to providers whose primary function is to facilitate access to comprehensive sexual and reproductive health care services and information for low-income, uninsured and underinsured individuals and provide support to providers to facilitate access to care, fund uncompensated care, and support community awareness of comprehensive sexual and reproductive health care services across New York state.
Establishes the New York state abortion clinical training program within the department of health for the purpose of training health care practitioners in the performance of abortion and related reproductive health care services; requires the commissioner of health to submit a report to the governor and the legislature.
